Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
Van Baelen K, Nguyen HL, Hamy-Petit AS, Richard F, Karsten MM, Nader Marta G, Vermeulen P, Toussaint A, Reyal F, Vincent-Salomon A, Dirix L, Dordevic AD, de Azambuja E, Larsimont D, Amato O, Maetens M, De Schepper M, Geukens T, Han SN, Baert T, Punie K, Wildiers H, Smeets A, Nevelsteen I, Floris G, Biganzoli E, Neven P, Desmedt C. Van Baelen K, et al. Eur J Cancer. 2023 Sep;191:112988. doi: 10.1016/j.ejca.2023.112988. Epub 2023 Jul 13. Eur J Cancer. 2023. PMID: 37573673 Free article.
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy.
Vincent-Salomon A, Carton M, Freneaux P, Palangie T, Beuzeboc P, Mouret E, de Crémoux P, Coué O, Zafrani B, Nicolas A, Clough K, Fourquet A, Pouillart P, Sastre-Garau X. Vincent-Salomon A, et al. Eur J Cancer. 2000 Mar;36(5):586-91. doi: 10.1016/s0959-8049(99)00339-1. Eur J Cancer. 2000. PMID: 10738122
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.
Vincent-Salomon A, Rousseau A, Jouve M, Beuzeboc P, Sigal-Zafrani B, Fréneaux P, Rosty C, Nos C, Campana F, Klijanienko J, Al Ghuzlan A, Sastre-Garau X; Breast Cancer Study Group. Vincent-Salomon A, et al. Eur J Cancer. 2004 Jul;40(10):1502-8. doi: 10.1016/j.ejca.2004.03.014. Eur J Cancer. 2004. PMID: 15196533
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, Radvanyi F, Salmon R, Thiery JP, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Delattre O; breast cancer study group of the Institut Curie. Vincent-Salomon A, et al. Clin Cancer Res. 2008 Apr 1;14(7):1956-65. doi: 10.1158/1078-0432.CCR-07-1465. Clin Cancer Res. 2008. PMID: 18381933
432 results